Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method

Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis

(2020) Anna L Funk et al.   LANCET INFECTIOUS DISEASES

Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis

(2020) Pauline Boucheron et al.   LANCET INFECTIOUS DISEASES

Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy

(2020) Marieke Bierhoff et al.   BMJ Open

Renal safety of tenofovir alafenamide vs tenofovir disoproxil fumarate

(2019) Samir K. Gupta et al.   AIDS

Hepatitis B infection in the general population of China: a systematic review and meta-analysis

(2019) Huai Wang et al.   BMC INFECTIOUS DISEASES

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

(2018) Norah A. Terrault et al.   HEPATOLOGY

Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother–infant pairs

(2018) Catriona Waitt et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

How to control highly endemic hepatitis B in Asia

(2018) Shan Shan et al.   LIVER INTERNATIONAL

Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China

(2018) Qiu-Ju Sheng et al.   MEDICINE

Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads

(2018) Yayun Lin et al.   Scientific Reports

Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine

(2017) Shaohang Cai et al.   MEDICINE

Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review

(2017) Soheil Tavakolpour et al.   Infectious Diseases

Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa

(2016) E. Keane et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus

(2016) Adrian S. Ray et al.   ANTIVIRAL RESEARCH

The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

(2016) Jeffrey D Stanaway et al.   LANCET

Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?

(2016) Marco Vitoria et al.   Journal of the International AIDS Society

Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption

(2016) Kenneth K. Mugwanya et al.   PLOS MEDICINE

Breast Milk Pharmacokinetics of Efavirenz and Breastfed Infants' Exposure in Genetically Defined Subgroups of Mother-Infant Pairs: An Observational Study

(2015) Adeniyi Olagunju et al.   CLINICAL INFECTIOUS DISEASES

Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi

(2015) Leonardo Palombi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults

(2014) M. Markowitz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Progesterone induces apoptosis of insulin-secreting cells: insights into the molecular mechanism

(2014) V A Nunes et al.   JOURNAL OF ENDOCRINOLOGY

Pharmacokinetics and Tolerability of Tenofovir Disoproxil Fumarate 300 mg Once Daily: An Open-Label, Single- and Multiple-Dose Study in Healthy Chinese Subjects

(2013) Chao-ying Hu et al.   CLINICAL THERAPEUTICS

Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy

(2013) K.W. Cheung et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strategies for intervention

(2013) Wan-Hsin Wen et al.   JOURNAL OF HEPATOLOGY

Management of chronic hepatitis B in pregnancy

(2012) Guo-Rong Han   WORLD JOURNAL OF GASTROENTEROLOGY

A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection

(2011) Guo-Rong Han et al.   JOURNAL OF HEPATOLOGY

Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Côte d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2

(2010) Sihem Benaboud et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Unknown

(2008) G. Birkus et al.   MOLECULAR PHARMACOLOGY